Drug class
Neuroprotective Agents clinical trials
A class of medicines: the studies that test any of its 28 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the neuroprotective agents studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
- Isospaglumic acid
- 2
- Sgs-742
- 2
- Tenocyclidine
- 1
- Tirilazad
- 1
- Eliprodil
- 1
- Nefiracetam
- 1
- Chlormethiazole
- 1
- Meclofenoxate
- 1
Studies by the year they started
935 studies that test it; most in 2021 (68)
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1992 | 1 |
| 1993 | 1 |
| 1994 | 3 |
| 1995 | 4 |
| 1996 | 1 |
| 1997 | 3 |
| 1998 | 4 |
| 1999 | 6 |
| 2000 | 7 |
| 2001 | 13 |
| 2002 | 12 |
| 2003 | 21 |
| 2004 | 28 |
| 2005 | 24 |
| 2006 | 19 |
| 2007 | 34 |
| 2008 | 30 |
| 2009 | 55 |
| 2010 | 32 |
| 2011 | 41 |
| 2012 | 40 |
| 2013 | 41 |
| 2014 | 30 |
| 2015 | 43 |
| 2016 | 37 |
| 2017 | 24 |
| 2018 | 33 |
| 2019 | 45 |
| 2020 | 40 |
| 2021 | 68 |
| 2022 | 38 |
| 2023 | 38 |
| 2024 | 38 |
| 2025 | 40 |
| 2026 | 40 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 191 · Other 753
Shionogi (18) · Novartis (13) · Novartis Pharmaceuticals (12) · Sound Pharmaceuticals, Incorporated (11) · Ain Shams University (11) · Teva Branded Pharmaceutical Products R&D, Inc. (10) · National Institute of Allergy and Infectious Diseases (NIAID) (9) · Kafrelsheikh University (9)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 944
- Cilostazol for Prevention of Recurrent Stroke TrialNot yet recruitingPhase 3Stanford UniversityNCT07174414Written as Cilostazol 100 mg Tablets
- Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial AneurysmsNot yet recruitingPhase 4Duan ChuanzhiNCT07353749Written as Methylprednisolone (Injectable Form)
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruitingPhase 2National Cancer Institute (NCI)NCT06317662Written as Methylprednisolone
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)RecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT03109288Written as Cilostazol
- Musculoskeletal Outcomes Using Tylenol/Ibuprofen vs. Oral Steroids in New InjuriesEnrolling by invitationPhase 4State University of New York at BuffaloNCT07393503Written as Methylprednisolone 4Mg Tab
- Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid HemorrhageRecruitingPhase 3Beijing Tiantan HospitalNCT07249853Written as Cilostazol 100 mg BID
- Efficacy and Safety of Butylphthalide in the Treatment of Multiple System AtrophyRecruitingPhase 2/3Second Affiliated Hospital, Zhejiang University, School of MedicineNCT07518810Written as 3-N-butylphthalide
- Ketorolac Versus Corticosteroid Injections for Sacroiliac Joint PainRecruitingEarly Phase 1McMaster UniversityNCT06081101Written as Methylprednisolone Injection
- Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis PlaquesRecruitingPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT02784210Written as Methylprednisolone
- Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic StrokeNot yet recruitingNot applicableNational Hospital of Acupuncture, VietnamNCT07846488Written as Cerebrolysin
- Methylprednisolone for Moderate to Severe Traumatic Brain InjuryRecruitingPhase 4Zhangjiagang First People's HospitalNCT07180277Written as Methylprednisolone (MP)
- A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 GangliosidosisRecruitingPhase 1/2National Human Genome Research Institute (NHGRI)NCT03952637Written as Methylprednisolone
- Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need VentilatorsRecruitingPhase 1/2Astellas Gene TherapiesNCT07052929Written as Methylprednisolone
- Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing LossRecruitingPhase 4Dr. Lutfi Kirdar Kartal Training and Research HospitalNCT06968507Written as Methylprednisolone (drug)
- A Multicenter Randomized Controlled Trial to Treat Acute T Cell Mediated Rejection in Kidney and Kidney-Pancreas Transplant RecipientsRecruitingPhase 3University of SydneyNCT06474273Written as Methylprednisolone
- Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological CancersRecruitingPhase 2Emory UniversityNCT06492070Written as Cilostazol
- Pharmacokinetics of Huperzine A Oral Solution in Healthy ParticipantsNot yet recruitingPhase 1Wanbangde Pharmaceutical Group Co., LTDNCT07784335Written as Huperzine A Oral Solution
- The Study of Ginkgo Leaf Dropping Pills and Huperzine A Injection Combined With Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain InjuryRecruitingPhase 4Wanbangde Pharmaceutical Group Co., LTDNCT06704334Written as Huperzine A injection
- Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)RecruitingPhase 4Igor Wilderman. MDNCT07762170Written as Depo-Medrol 40Mg/Ml Suspension for Injection
- Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Pediatric Critical AsthmaRecruitingPhase 2Johns Hopkins All Children's HospitalNCT07455396Written as Methylprednisolone
See all 944 studies that test one of the neuroprotective agents →